![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, June 15, 2014 12:20:34 PM
"This makes the effort of recruiting qualified patients, and retaining those enrolled patients through the end of a study, the greatest barriers to clinical trial completion and time to a full data set for analysis and evaluation. Nearly eighty percent of clinical trials in the U.S. do not meet enrollment timelines and dropout rates are significant."
http://patientpoint.com/blog/technology-helps-recruit-and-enroll-the-right-patients-for-clinical-trials
"Big pharma" will demand access to LymPro.
Stay tuned for news.
Twitter: @AmarantusBio .... 10,000 followers.
FEATURED North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM